van Weperen V, Vaseghi M
Front Neurosci. 2023; 17:1192188.
PMID: 37351426
PMC: 10282187.
DOI: 10.3389/fnins.2023.1192188.
van Weperen V, Ripplinger C, Vaseghi M
Clin Auton Res. 2023; 33(4):491-517.
PMID: 37166736
PMC: 10173946.
DOI: 10.1007/s10286-023-00948-8.
Dorn 2nd G
Am J Physiol Cell Physiol. 2022; 323(2):C461-C477.
PMID: 35759434
PMC: 9363002.
DOI: 10.1152/ajpcell.00167.2022.
Weldy C, Ashley E
Nat Rev Cardiol. 2021; 18(11):745-762.
PMID: 34108678
DOI: 10.1038/s41569-021-00566-9.
Borovac J, DAmario D, Bozic J, Glavas D
World J Cardiol. 2020; 12(8):373-408.
PMID: 32879702
PMC: 7439452.
DOI: 10.4330/wjc.v12.i8.373.
Biomarkers in heart failure: the past, current and future.
Sarhene M, Wang Y, Wei J, Huang Y, Li M, Li L
Heart Fail Rev. 2019; 24(6):867-903.
PMID: 31183637
DOI: 10.1007/s10741-019-09807-z.
Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: method development for a translational research study.
Denfeld Q, Habecker B, Woodward W
BMC Res Notes. 2018; 11(1):248.
PMID: 29673396
PMC: 5909231.
DOI: 10.1186/s13104-018-3352-3.
Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance.
Cohen-Solal A, Jacobson A, Pina I
ESC Heart Fail. 2017; 4(4):499-506.
PMID: 29154422
PMC: 5695165.
DOI: 10.1002/ehf2.12153.
Is Heart Rate a Norepiphenomenon in Heart Failure?.
Hensey M, ONeill J
Curr Cardiol Rep. 2016; 18(9):91.
PMID: 27457085
DOI: 10.1007/s11886-016-0764-3.
Cardiac innervation and sudden cardiac death.
Fukuda K, Kanazawa H, Aizawa Y, Ardell J, Shivkumar K
Circ Res. 2015; 116(12):2005-19.
PMID: 26044253
PMC: 4465108.
DOI: 10.1161/CIRCRESAHA.116.304679.
Beta-blocker therapy in unstable severe heart failure, evidence or experience?.
Meuwese C, Kirkels J, de Jonge N, Nathoe H, Doevendans P, Klopping C
Neth Heart J. 2012; 21(1):3-5.
PMID: 23239450
PMC: 3528855.
DOI: 10.1007/s12471-012-0366-7.
B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?.
Welsh P, McMurray J
Diabetologia. 2012; 55(5):1240-3.
PMID: 22398647
DOI: 10.1007/s00125-012-2515-3.
Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.
Gruson D, Thys F, Verschuren F
Mol Diagn Ther. 2011; 15(6):327-40.
PMID: 22188636
DOI: 10.1007/BF03256468.
Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.
Shan J, Kushnir A, Betzenhauser M, Reiken S, Li J, Lehnart S
J Clin Invest. 2010; 120(12):4388-98.
PMID: 21099118
PMC: 2993575.
DOI: 10.1172/JCI32726.
Altered firing pattern of single-unit muscle sympathetic nerve activity during handgrip exercise in chronic heart failure.
Murai H, Takamura M, Maruyama M, Nakano M, Ikeda T, Kobayashi D
J Physiol. 2009; 587(Pt 11):2613-22.
PMID: 19403612
PMC: 2714025.
DOI: 10.1113/jphysiol.2009.172627.
Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction.
Yoh M, Yuasa F, Mimura J, Yokoe H, Kawamura A, Sugiura T
J Nucl Cardiol. 2009; 16(2):244-50.
PMID: 19159993
DOI: 10.1007/s12350-008-9039-8.
Of fight and flight.
Gerson M, Abdul-Waheed M, Millard R
J Nucl Cardiol. 2009; 16(2):176-9.
PMID: 19159992
DOI: 10.1007/s12350-008-9040-2.
Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction.
Duncker D, de Beer V, Merkus D
Med Biol Eng Comput. 2008; 46(5):485-97.
PMID: 18320249
PMC: 2329737.
DOI: 10.1007/s11517-008-0315-1.
THE CONTROL OF VENTRICULAR FUNCTION IN MAN.
Braunwald E
Br Heart J. 1965; 27:1-16.
PMID: 14242160
PMC: 490129.
DOI: 10.1136/hrt.27.1.1.
CARDIAC NOREPHINEPHRINE STORES IN EXPERIMENTAL HEART FAILURE IN THE DOG.
Chidsey C, KAISER G, SONNENBLICK E, Spann J, Braunwald E
J Clin Invest. 1964; 43:2386-93.
PMID: 14234835
PMC: 289667.
DOI: 10.1172/JCI105113.
